Μετάβαση στο περιεχόμενο

ΕτικέταKeytruda

Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program

The U.S. Food and Drug Administration (FDA) granted Merck & Co.’s Keytruda another approval, this one in combination with Alimta (pemetrexed) and platinum chemotherapy for first-line treatment of metastatic non-small cell lung cancer (NSCLC), with … Continue Reading Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program

Bristol-Myers Squibb’s Opdivo Gets New Approval for Lung Cancer Indication

The U.S. Food and Drug Administration (FDA) gave Bristol-Myers Squibb’s Opdivo (nivolumab) approval for metastatic small cell lung cancer (SCLC) for patients whose cancer has progressed after platinum-based chemotherapy and at least one other type of … Continue Reading Bristol-Myers Squibb’s Opdivo Gets New Approval for Lung Cancer Indication